Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

June 1, 2010

Primary Completion Date

November 2, 2012

Study Completion Date

November 30, 2012

Conditions
Eyelash HypotrichosisAlopecia Areata
Interventions
DRUG

bimatoprost ophthalmic solution 0.03%

One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margin (where the eyelashes meet the skin) once nightly for 4 months.

DRUG

Vehicle Sterile Solution

One drop applied to a sterile single-use-per-eye applicator and applied to upper eyelid margin (where the eyelashes meet the skin) once nightly for 4 months.

Trial Locations (2)

Unknown

Newport Beach

São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY